When using dopps slides
Download
1 / 21

When Using DOPPS Slides - PowerPoint PPT Presentation


  • 130 Views
  • Uploaded on

When Using DOPPS Slides. DOPPS Slide Use Guidelines. C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Introduction. DOPPS Background (1). DOPPS Background (2). Methods.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' When Using DOPPS Slides' - tyler


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript


C-Reactive Protein (CRP) and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)






Table 1 baseline patient characteristics by crp level above and below 3 0 mg l japan only 1
Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (1)


Table 1 baseline patient characteristics by crp level above and below 3 0 mg l japan only 2
Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (2)


Table 1 baseline patient characteristics by crp level above and below 3 0 mg l japan only 3
Table 1. Baseline Patient Characteristics by CRP Level Above and Below 3.0 mg/L, Japan Only (3)


Table 2. Baseline Characteristics for Patients by High Above and Below 3.0 mg/L, Japan Only (3)vs Low Facility Percentage CRP Measurement, all DOPPS Countries Except US and Canada (1)


Table 2. Baseline Demographics for Patients by High Above and Below 3.0 mg/L, Japan Only (3)vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (2)


Table 2. Baseline Demographics for Patients by High Above and Below 3.0 mg/L, Japan Only (3)vs Low Facility Percentage CRP Measurement, all Countries Except US and Canada (3)



Conclusions
Conclusions of Patients with CRP Measurement


Acknowledgements
Acknowledgements of Patients with CRP Measurement


ad